XML 39 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
NET INCOME (LOSS) PER SHARE OF COMMON STOCK
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
NET INCOME (LOSS) PER SHARE OF COMMON STOCK NET INCOME (LOSS) PER SHARE OF COMMON STOCK
The Company is required to utilize the “two-class” method of computing basic and diluted net income per share because the Company issued certain PIPRs, including certain P-PIPRs, which are treated as participating securities.
The Company’s basic and diluted net income (loss) per share calculations using the “two-class” method for the three month periods ended March 31, 2024 and 2023 are presented below:
Three Months Ended
March 31,
20242023
Net income (loss) attributable to Lazard$35,755 $(22,172)
Adjustment for earnings attributable to participating securities(1,279)(1,125)
Net income (loss) attributable to Lazard - basic34,476 (23,297)
Adjustment for earnings attributable to participating securities195 – 
Net income (loss) attributable to Lazard - diluted$34,671 $(23,297)
Weighted average number of shares of common stock outstanding88,547,75785,734,443
Weighted average number of shares of common stock issuable on a non-contingent basis2,712,7081,857,409
Weighted average number of shares of common stock outstanding - basic91,260,46587,591,852
Weighted average number of incremental shares of common stock issuable from share-based incentive compensation (a)8,091,304
Weighted average number of shares of common stock outstanding - diluted99,351,76987,591,852
Net income (loss) attributable to Lazard per share of common stock:
Basic$0.38 $(0.27)
Diluted$0.35 $(0.27)
___________________________________
(a)The aggregate weighted average number of incremental shares of common stock issuable from PIPRs for the three month period ended March 31, 2024 of 2,167,520 and from RSUs, PRSUs and PIPRs for the three month period ended March 31, 2023 of 6,046,499, that could be potentially dilutive in future periods, have been excluded from the computation of diluted net income (loss) per share as the effect would be antidilutive in the respective periods.